Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S. Position Summary: The Vice President of Medical Affairs will provide global strategic direction and tactical execution of medical affairs activities at Alkeus with an initial focus in the gildeuretinol program. Reporting to the Chief Medical Officer, the VP of Medical Affairs will lead a cross-functional medical organization spanning Patient Advocacy, Medical and Scientific Communications, Medical Directors, Medical Operations, Medical Information, and Field Medical (MSLs). Collaborating closely with Clinical Development, Regulatory, Commercial, and other functions within and outside the company, this role will ensure scientific excellence across stakeholder engagement, evidence generation, medical communications, and phase 3 trial support activities. This individual will represent the medical perspective across senior leadership forums within the company and to outside stakeholders as appropriate. This leader will create a modern, compliant, and evidence-based Medical Affairs team that meaningfully serves patients.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
1-10 employees